Results 261 to 270 of about 746,792 (308)

Biomarkers of neuroendocrine tumors

Annales de biologie clinique, 2016
Neuroendocrine tumors (NET) are rare heterogenous tumors which prevalence is increasing. Their features vary by anatomical location, functionality and hormonal production. Their management needs a multidisciplinary approach. Functional tumors develop characteristic clinical syndromes in contrast to non-functional tumors that are diagnosed fortuitously ...
Michèle, d'Herbomez   +5 more
openaire   +2 more sources

Biomarkers in airway tumors

International Journal of Oncology, 1996
Despite advances and improvements in diagnosis and treatment of upper aerodigestive tumors including head and neck and lung cancers, the overall survival rate of these patients remains poor. Prevention, early diagnosis, and novel therapy are under active investigation to improve the outcome of the diseases.
D, Shin, W, Hong
openaire   +2 more sources

MRI biomarkers in osseous tumors

Journal of Magnetic Resonance Imaging, 2019
Although radiography continues to play a critical role in osseous tumor assessment, there have been remarkable advances in cross‐sectional imaging. MRI has taken a lead in this assessment due to high tissue contrast and spatial resolution, which are well suited for bone lesion assessment.
Takeshi Fukuda   +4 more
openaire   +2 more sources

Biomarkers in pediatric tumors

Clinical Biochemistry, 2014
PubMed ID ...
openaire   +3 more sources

Survivin: A promising tumor biomarker

Cancer Letters, 2007
Survivin is a 16.5 kDa protein overexpressed in almost all malignancies but rarely detected in normal differentiated adult tissues. Functionally, survivin has been shown to inhibit apoptosis, promote cell proliferation and enhance angiogenesis. Consistent with its role in these processes, survivin has been shown to play a key role in cancer progression.
Michael J, Duffy   +4 more
openaire   +2 more sources

Urinary Biomarkers in Tumors: An Overview

2021
Recent reports suggest that urine is a useful noninvasive tool for the identification of urogenital tumors, including bladder, prostate, kidney, and other nonurological cancers. As a liquid biopsy, urine represents an important source for the improvement of new promising biomarkers, a suitable tool to identify indolent cancer and avoid overtreatment ...
Ilaria, Cimmino   +2 more
openaire   +2 more sources

New Tumor Biomarkers

2007
This chapter describes the key elements in tumor biomarker development toward clinical use. In particular, it focuses on the analytical aspects of assay development and how to implement new tumor biomarkers in the clinical setting.
Nils Brünner   +5 more
openaire   +1 more source

Machine Learning & Molecular Radiation Tumor Biomarkers

Seminars in Radiation Oncology, 2023
Developing radiation tumor biomarkers that can guide personalized radiotherapy clinical decision making is a critical goal in the effort towards precision cancer medicine. High-throughput molecular assays paired with modern computational techniques have the potential to identify individual tumor-specific signatures and create tools that can help ...
Nicholas R, Rydzewski   +6 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy